SERUMSPRÄPARAT

European patent · EP2619540 · In force

Register entry

Publication number
EP2619540
Application number
EP11826220
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Sep 20, 2011
Published
Jul 31, 2013
Granted
Mar 21, 2018
Protection ends at the latest
Sep 19, 2031
Next annual fee due
Sep 30, 2027
IPC classes
G01N 1/28 (2006.01)
G01N 33/50 (2006.01)
G01N 33/68 (2006.01)
Priority
AU 2010904233 20.09.2010
PCT application
PCT/AU2011/001221 20.09.2011
PCT publication
WO2012/037609 29.03.2012
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.09.2026 → 30.09.2027

    Published in Swissreg on 01.10.2026

  2. Oct 1, 2025

    Next annual fee due on

    Next annual fee due on
    30.09.2025 → 30.09.2026

    Published in Swissreg on 01.10.2025

  3. Oct 3, 2024

    Change

    Published in Swissreg on 03.10.2024

  4. Oct 1, 2023

    Change

    Published in Swissreg on 01.10.2023

  5. Oct 11, 2022

    Change

    Published in Swissreg on 11.10.2022

  6. Mar 21, 2018

    Granted

    Published in Swissreg on 21.03.2018

Parties

Holder

Q-Sera Pty Ltd

Level 9, 31 Queen Street, Melbourne, Victoria 3000, AU

Inventor

MASCI, Paul

St Lucia, Queensland 4072, AU

DE JERSEY, John

St Lucia, Queensland 4072, AU

LAVIN, Martin

St Lucia, Queensland 4072, AU

PHILLIPS, Julie

Denistone New South Wales 2114, AU

DIMESKI, Goce

Hamilton, Queensland 4007, AU

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.